Related Experiment Videos
Summary
Primary bladder adenocarcinoma is rare. Radical cystectomy offered long-term survival for low-stage patients, highlighting the importance of clinical stage in bladder cancer prognosis.
Area of Science:
- Urology
- Oncology
Background:
- Primary adenocarcinoma of the bladder is a rare malignancy, accounting for 1.5% of all bladder cancers.
- This study reviews cases treated at the Virginia Mason Medical Center since 1959.
Purpose of the Study:
- To evaluate the prognostic factors influencing survival in patients with primary bladder adenocarcinoma.
- To identify optimal treatment strategies for improved patient outcomes.
Main Methods:
- Retrospective analysis of 10 patients diagnosed with primary bladder adenocarcinoma.
- Correlation of survival rates with histologic grade, tumor location, and clinical stage.
Main Results:
- Histologic grade and tumor location showed variable effects on patient survival.
- Clinical stage demonstrated a direct correlation with survival outcomes.
- Four patients with low-stage disease who underwent radical cystectomy achieved long-term survival.
Conclusions:
- Clinical stage is a critical determinant of survival in primary bladder adenocarcinoma.
- Radical cystectomy appears to be an effective treatment for low-stage disease, leading to long-term survival.